These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 14608514

  • 1. [Dementia].
    Diehl RR.
    Fortschr Neurol Psychiatr; 2003 Nov; 71(11):617-28. PubMed ID: 14608514
    [No Abstract] [Full Text] [Related]

  • 2. [Dementia].
    Sjöbeck M, Nilsson C.
    Lakartidningen; 2003 Nov; 106(20):1369-73. PubMed ID: 19585832
    [No Abstract] [Full Text] [Related]

  • 3. [Cholesterol inhibitor and memantine in symptomatic dementia therapy].
    Rodda J, Carter J.
    Praxis (Bern 1994); 2013 Feb 27; 102(5):293-300; discussion 298-9. PubMed ID: 23446240
    [No Abstract] [Full Text] [Related]

  • 4. New developments in the treatment of Alzheimer's disease.
    J Clin Psychiatry; 2009 Feb 27; 70(2):281-90. PubMed ID: 19265644
    [No Abstract] [Full Text] [Related]

  • 5. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D.
    Clin Geriatr Med; 2004 Feb 27; 20(1):59-68. PubMed ID: 15062487
    [No Abstract] [Full Text] [Related]

  • 6. [Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].
    MMW Fortschr Med; 2003 Jun 05; 145(23):60. PubMed ID: 12854234
    [No Abstract] [Full Text] [Related]

  • 7. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():21. PubMed ID: 14579479
    [No Abstract] [Full Text] [Related]

  • 8. [Drug therapy of Alzheimer dementia].
    Skausig OB, Laugesem LP, Jensen T.
    Ugeskr Laeger; 2003 Jul 14; 165(29):2899; author reply 2899-900. PubMed ID: 12908363
    [No Abstract] [Full Text] [Related]

  • 9. Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
    Burns A, O'Brien J, BAP Dementia Consensus group, Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D, British Association for Psychopharmacology.
    J Psychopharmacol; 2006 Nov 14; 20(6):732-55. PubMed ID: 17060346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Early diagnosis and treatment of dementia].
    Froböse T, Kurz A.
    MMW Fortschr Med; 2011 Sep 22; 153(38):86-9; quiz 90. PubMed ID: 21977802
    [No Abstract] [Full Text] [Related]

  • 19. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005].
    Wellhöfer B.
    Dtsch Med Wochenschr; 2006 Feb 10; 131(6):284. PubMed ID: 16463237
    [No Abstract] [Full Text] [Related]

  • 20. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2007 Feb 10; 5(54):9-14. PubMed ID: 17261969
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.